Japan Electroceuticals Market

Japan Electroceuticals Market Size, Share & Trends Analysis Report by Product (Cardioverter Defibrillators and Cardiac Pacemaker, Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators, Cochlear Implants, and Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)), by End-User (Hospitals and Clinics, and Homecare and Other), Forecast Period 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jan 2020 | Report Code: OMR2020256 | Category : Medical Devices | Delivery Format: /

Japan electroceuticals market is expected to grow at a CAGR of 7.1% during the forecast period. Geriatric population is one of the major concerns for the Japanese government and other healthcare institution. According to US Census Bureau, out of total 126 million population, about 27% population of the country was above 65 years in 2017. It is forecast that the population will reduce to 123 million in 2023 and geriatric population is forecast to be higher as compared to 2017. Additionally, life expectancy of the people in Japan is the highest globally. The incidence of heart stroke occurrence in geriatric population is relatively high as compared to young population. As per the Institute for Health Metrics and Evaluation, in 2017, around 0.2 million incidences of ischemic heart disease occurred in Japan. The prevalence of Ischemic heart disease in 2013 was 3.5 million peoples that have increased to 3.7 million in 2017.

The other major factor that provides significant growth to the market is product approval in the country. LivaNova had received Japan’s Ministry of Health, Labour & Welfare approval for Perceval suture less aortic heart valve to treat aortic valve disease that enables to provide patients and clinicians in Japan with a new option for aortic heart valve replacement. Additionally, the company had received the US FDA 510(k) clearance of the MEMO4D semi-rigid mitral annuloplasty ring and confirmed the first implantation of the device.

The market is segmented on the basis of product and end-user. On the basis of product, the market is segmented into cardioverter defibrillators and cardiac pacemaker, deep brain stimulators (DBS), spinal cord stimulators (SCS), vagus nerve stimulators, hearing aids, and cochlear implants, and others such as sacral nerve stimulators, and transcutaneous electrical nerve stimulators. By end-user segment, the market is segmented into hospitals & clinics and homecare and other. Few players operating in the Japan electroceuticals market include Medtronic PLC, Abbott Laboratories Inc., Boston Scientific Corp., LivaNova PLC, Cochlear, Ltd., Sonova Holding AG, Nevro Corp., ElectroCore LLC, and BioElectronics Corp.

Research Methodology

The market study of the Japan electroceuticals market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  1. Japan Electroceuticals Market Research and Analysis by Product 
  2. Japan Electroceuticals Market Research and Analysis by End-User

The Report Covers

  • Comprehensive research methodology of the Japan electroceuticals market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Japan electroceuticals market.
  • Insights about market determinants which are stimulating the Japan electroceuticals market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Japan Electroceuticals Market by Product and its Application

5.1.1. Cardioverter Defibrillators and Cardiac Pacemaker

5.1.1.1. Arrhythmias

5.1.2. Deep Brain Stimulators

5.1.2.1. Parkinson’s Disease

5.1.2.2. Depression

5.1.3. Spinal Cord Stimulators

5.1.3.1. Failed Back Syndrome

5.1.3.2. Ischemia

5.1.4. Vagus Nerve Stimulators

5.1.4.1. Epilepsy

5.1.5. Cochlear Implants

5.1.5.1. Sensorineural Hearing Loss

5.1.6. Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)

5.1.6.1. Urinary Incontinence

5.1.6.2. Treatment-Resistant Depression

5.2. Japan Electroceuticals Market by End-User

5.2.1. Hospitals and Clinics

5.2.2. Homecare and Other

6. Company Profiles

6.1. Abbott Laboratories Inc.

6.2. Boston Scientific Corp.

6.3. Century Medical, Inc.

6.4. Demant A/S

6.5. Edwards Lifesciences Corp.

6.6. Getinge AB

6.7. GlaxoSmithKline PLC

6.8. Livanova PLC

6.9. Medtronic PLC

6.10. Renishaw PLC

6.11. Sonova Holding AG

6.12. Sorin CRM SAS

6.13. Terumo Corp.

1. JAPAN ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

2. JAPAN ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION) 

1. JAPAN ELECTROCEUTICALS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)

2. JAPAN ELECTROCEUTICALS MARKET SHARE BY END-USER, 2018 VS 2025 (%)